Shandong Xinhua Pharmaceutical (HKG:0719) received the drug registration certificate for erectile dysfunction drug Sildenafil Citrate Orodispersible tablets from China's National Medical Products Administration, a Tuesday Hong Kong bourse filing said.
Shandong Zibo Xincat Pharmaceutical, a unit of the pharmaceutical firm, also obtained a registration certificate for its Ursodeoxycholic Acid Capsules, indicated for the treatment of gallbladder cholesterol stones, from the regulator, a separate filing said.